Common Erectile Dysfunction Drug Linked to Increased Glaucoma Risk, Study Finds

Recent research has revealed a potential link between tadalafil, a medication commonly prescribed for erectile dysfunction under the brand name Cialis, and an elevated risk of developing glaucoma—a serious eye condition that can lead to vision loss. This finding is particularly relevant for men using the drug to manage urinary tract issues related to an enlarged prostate.

The study, published in the British Journal of Ophthalmology, suggests that men taking tadalafil on a long-term basis may need to undergo regular eye exams, especially if they have existing risk factors for glaucoma. These risk factors include a family history of the disease or conditions such as ocular hypertension, which is characterized by increased pressure within the eye.

Medical experts not involved in the study have noted that while the risk of developing glaucoma from long-term use of Cialis is present, it remains relatively low. Dr. S. Adam Ramin, a urologist and medical director of Urology Cancer Specialists in Los Angeles, emphasized that the majority of patients who use Cialis for erectile dysfunction do so occasionally, which minimizes their risk.

The study examined medical records of over 70,000 men aged 40 and older, none of whom had a prior history of glaucoma. Researchers found that those who took tadalafil were 22% more likely to develop glaucoma than those who did not use the medication. Furthermore, there were significant increases in the likelihood of developing ocular hypertension and primary open-angle glaucoma among tadalafil users.

Despite the findings, Dr. Craig Comiter, a urology professor at Stanford University, reassured patients that the absolute increase in risk remains under 1% for those using tadalafil daily. He highlighted the importance of monitoring for individuals with known risk factors and maintaining regular ophthalmologic care.

Additionally, it’s important to note that tadalafil is part of a class of medications known as phosphodiesterase type 5 inhibitors (PDE5i), which includes other drugs like sildenafil, commonly marketed as Viagra. The American Academy of Ophthalmology has previously identified that these medications may cause minor vision-related side effects, such as light sensitivity and color vision changes.

For those concerned about the findings, Ramin pointed out that there are alternative treatments available for urinary tract issues associated with benign prostatic enlargement. He encouraged shared decision-making between patients and their healthcare providers to find the most suitable treatment plan.

Glaucoma itself is primarily caused by elevated intraocular pressure, which can damage the optic nerve and lead to significant vision impairment. Early detection is crucial, as many individuals may remain unaware of their condition until substantial vision loss occurs. Regular eye examinations are essential for identifying high eye pressure and initiating treatment to prevent progression.

As the study highlights, men using tadalafil should be aware of this potential risk and consider consulting their healthcare providers about appropriate eye care, particularly if they have pre-existing conditions that could heighten their chances of developing glaucoma.